Physician profile
Pamela E Dorne
NPI 1265512693
$2,108.75
in general payments reported to CMS, 2019-2025
25 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $333 · 2021: $365 · 2022: $576 · 2023: $405 · 2024: $114 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $640.89 | 2020-2023 | Lo Loestrin Fe, Liletta |
| Gynesonics, INC. | $173.05 | 2022 | |
| Avion Pharmaceuticals | $155.02 | 2020-2023 | Balcoltra |
| Exeltis, USA INC. | $125.15 | 2022-2025 | Slynd, Tyblume |
| Myriad Women'S Health, INC. | $116.29 | 2023 | Myrisk |
| Allergan, INC. | $99.75 | 2019-2020 | |
| Hologic Sales and Service, LLC | $96.41 | 2019-2024 | Aptima, Fluent Fluid Management System |
| Aspira Women'S Health INC | $85.30 | 2022-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $66.34 | 2022-2023 | |
| Exact Sciences Corporation | $62.64 | 2025 | The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $61.59 | 2021-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $58.46 | 2019-2021 | |
| Astellas Pharma US INC | $52.57 | 2023 | Veozah |
| Agile Therapeutics, INC. | $51.79 | 2021 | |
| Medicem INC. | $45.01 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $34.35 | 2020 | |
| Amag Pharmaceuticals, INC. | $32.31 | 2019 | |
| Myovant Sciences INC. | $26.26 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.63 | 2022 | |
| Lupin INC. | $22.72 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.03 | 2020 | |
| Ferring Pharmaceuticals INC. | $17.72 | 2019 | |
| Minerva Surgical, INC | $14.18 | 2019 | |
| Millicent US INC | $13.47 | 2025 | Femlyv |
| Dysis Medical, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Dorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.